Unison Bio-Tech Industries Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.30 M
as on 19-12-2024
- Company Age 33 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 2.50 M
as on 19-12-2024
- Revenue %
(FY 2020)
- Profit 16.70%
(FY 2020)
- Ebitda
- Net Worth -19.63%
(FY 2020)
- Total Assets -2.73%
(FY 2020)
About Unison Bio-Tech Industries
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.50 M.
Sivannarayana Nallamothula and Vijaya Nallamothula serve as directors at the Company.
- CIN/LLPIN
U99999MH1991PTC061947
- Company No.
061947
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 1991
- Date of AGM
02 Jul 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unison Bio-Tech Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivannarayana Nallamothula  | Director | 01-Apr-2010 | Current |
| Vijaya Nallamothula | Director | 07-May-2018 | Current |
Financial Performance of Unison Bio-Tech Industries.
Unison Bio-Tech Industries Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 16.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Unison Bio-Tech Industries?
In 2020, Unison Bio-Tech Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Atharva Moulds Private LimitedActive 18 years 8 monthsSivannarayana Nallamothula and Vijaya Nallamothula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Shamrao Vitthal Co-Operative Bank Limited Creation Date: 06 Dec 2010 | ₹2.50 M | Open |
How Many Employees Work at Unison Bio-Tech Industries?
Unlock and access historical data on people associated with Unison Bio-Tech Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unison Bio-Tech Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unison Bio-Tech Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
